Logo image of XOS

XOS INC (XOS) Stock Fundamental Analysis

NASDAQ:XOS - Nasdaq - US98423B3069 - Common Stock - Currency: USD

3.38  -0.03 (-0.88%)

Fundamental Rating

2

XOS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 127 industry peers in the Machinery industry. Both the profitability and financial health of XOS have multiple concerns. XOS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year XOS has reported negative net income.
XOS had a negative operating cash flow in the past year.
XOS had negative earnings in 4 of the past 5 years.
In the past 5 years XOS always reported negative operating cash flow.
XOS Yearly Net Income VS EBIT VS OCF VS FCFXOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

XOS's Return On Assets of -56.27% is on the low side compared to the rest of the industry. XOS is outperformed by 89.76% of its industry peers.
XOS has a worse Return On Equity (-198.90%) than 90.55% of its industry peers.
Industry RankSector Rank
ROA -56.27%
ROE -198.9%
ROIC N/A
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XOS Yearly ROA, ROE, ROICXOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300 -400

1.3 Margins

XOS has a worse Gross Margin (4.91%) than 92.13% of its industry peers.
XOS's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for XOS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 4.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
XOS Yearly Profit, Operating, Gross MarginsXOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

2

2. Health

2.1 Basic Checks

XOS does not have a ROIC to compare to the WACC, probably because it is not profitable.
XOS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for XOS has been reduced compared to 5 years ago.
XOS has a better debt/assets ratio than last year.
XOS Yearly Shares OutstandingXOS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
XOS Yearly Total Debt VS Total AssetsXOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -3.90, we must say that XOS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -3.90, XOS is not doing good in the industry: 89.76% of the companies in the same industry are doing better.
XOS has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
XOS has a Debt to Equity ratio of 0.03. This is in the better half of the industry: XOS outperforms 79.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -3.9
ROIC/WACCN/A
WACC9.19%
XOS Yearly LT Debt VS Equity VS FCFXOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

2.3 Liquidity

A Current Ratio of 1.61 indicates that XOS should not have too much problems paying its short term obligations.
The Current ratio of XOS (1.61) is worse than 70.08% of its industry peers.
XOS has a Quick Ratio of 1.61. This is a bad value and indicates that XOS is not financially healthy enough and could expect problems in meeting its short term obligations.
XOS has a Quick ratio of 0.77. This is in the lower half of the industry: XOS underperforms 78.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 0.77
XOS Yearly Current Assets VS Current LiabilitesXOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

XOS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.09%, which is quite impressive.
Looking at the last year, XOS shows a decrease in Revenue. The Revenue has decreased by -8.13% in the last year.
The Revenue has been growing by 117.49% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)48.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
Revenue 1Y (TTM)-8.13%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%-55.33%

3.2 Future

The Earnings Per Share is expected to grow by 13.60% on average over the next years. This is quite good.
XOS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.03% yearly.
EPS Next Y32.23%
EPS Next 2Y23%
EPS Next 3Y13.6%
EPS Next 5YN/A
Revenue Next Year-9.74%
Revenue Next 2Y7.13%
Revenue Next 3Y7.56%
Revenue Next 5Y9.03%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XOS Yearly Revenue VS EstimatesXOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M
XOS Yearly EPS VS EstimatesXOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

XOS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XOS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XOS Price Earnings VS Forward Price EarningsXOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XOS Per share dataXOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

XOS's earnings are expected to grow with 13.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23%
EPS Next 3Y13.6%

More info and screens

0

5. Dividend

5.1 Amount

XOS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XOS INC

NASDAQ:XOS (7/15/2025, 12:22:44 PM)

3.38

-0.03 (-0.88%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners2.79%
Inst Owner Change0%
Ins Owners24.65%
Ins Owner Change-0.15%
Market Cap28.09M
Analysts80
Price Target6.12 (81.07%)
Short Float %11.7%
Short Ratio20.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-54.84%
Min EPS beat(2)-97.18%
Max EPS beat(2)-12.49%
EPS beat(4)2
Avg EPS beat(4)-7.13%
Min EPS beat(4)-97.18%
Max EPS beat(4)49.25%
EPS beat(8)4
Avg EPS beat(8)-4.14%
EPS beat(12)7
Avg EPS beat(12)2.38%
EPS beat(16)8
Avg EPS beat(16)-6.59%
Revenue beat(2)0
Avg Revenue beat(2)-39.44%
Min Revenue beat(2)-42.74%
Max Revenue beat(2)-36.13%
Revenue beat(4)0
Avg Revenue beat(4)-29.33%
Min Revenue beat(4)-42.74%
Max Revenue beat(4)-7.02%
Revenue beat(8)2
Avg Revenue beat(8)-18.49%
Revenue beat(12)3
Avg Revenue beat(12)-17.87%
Revenue beat(16)5
Avg Revenue beat(16)-19%
PT rev (1m)0%
PT rev (3m)-35.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.79%
EPS NY rev (1m)-10.05%
EPS NY rev (3m)-6.08%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)1.12%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.58
P/FCF N/A
P/OCF N/A
P/B 1.13
P/tB 1.13
EV/EBITDA N/A
EPS(TTM)-5.57
EYN/A
EPS(NY)-2.98
Fwd EYN/A
FCF(TTM)-4.72
FCFYN/A
OCF(TTM)-4.69
OCFYN/A
SpS5.86
BVpS2.99
TBVpS2.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -56.27%
ROE -198.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 4.91%
FCFM N/A
ROA(3y)-56.86%
ROA(5y)-56.23%
ROE(3y)-127.49%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-24.85%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 9.33%
Cap/Sales 0.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 0.77
Altman-Z -3.9
F-Score4
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)244.18%
Cap/Depr(5y)306.81%
Cap/Sales(3y)14.15%
Cap/Sales(5y)31.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30%
EPS Next Y32.23%
EPS Next 2Y23%
EPS Next 3Y13.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.13%
Revenue growth 3Y122.95%
Revenue growth 5Y117.49%
Sales Q2Q%-55.33%
Revenue Next Year-9.74%
Revenue Next 2Y7.13%
Revenue Next 3Y7.56%
Revenue Next 5Y9.03%
EBIT growth 1Y18.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year61.03%
EBIT Next 3Y16.69%
EBIT Next 5Y9.51%
FCF growth 1Y68.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.21%
OCF growth 3YN/A
OCF growth 5YN/A